FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253240757> ?p ?o ?g. }

• W4253240757 abstract "The anti-cyclic citrullinated peptide (anti-CCP) enzyme-linked immunosorbent assay has a high sensitivity and specificity for rheumatoid arthritis (RA). It has been used in especially early diagnosis of RA, and used to discriminate from other forms of arthritis. Anti-CCP positivity is unknown in brucellosis presented with peripheric arthritis (BPA), like other rheumatic diseases. The objective of this study was to investigate the positivity of anti-CCP in patients with BPA in contrast to the patients with RA and healthy controls. Additionally, we have aimed to monitor changes of anti-CCP levels following the brucellosis treatment. The study group consisted of 137 subjects. 62 brucellosis patients presented with peripheric arthritis. Additionally, 33 RA patients and 42 healthy subjects selected as control groups. The anti-CCP, rheumatoid factor and anti-nuclear antibody levels of the subjects were measured. Concerning the 62 BPA, 20 % (13 patients) of them had elevated anti-CCP levels. On the other side, of the 33 RA patients, 78.78 % (26 patients) of them had increased anti-CCP levels. Only one healthy subject’s anti-CCP level was positive. There was statistically significant difference among the groups. After brucellosis treatment, monitorisation of the 13 patients with BPA who have the positive anti-CCP levels, were challengingly interesting because none of the patients had positive anti-CCP levels. Anti-CCP may be positive marker in the diagnosis of BPA but clinicians need to be careful during the follow up period because it may turn into normal ranges. Additionally, patients presented with peripheric arthritis and anti-CCP positivity need to be evaluated also for the differential diagnosis of BPA." @default.
• W4253240757 created "2022-05-12" @default.
• W4253240757 creator A5014873964 @default.
• W4253240757 creator A5016930658 @default.
• W4253240757 creator A5017389872 @default.
• W4253240757 creator A5031250517 @default.
• W4253240757 creator A5037729679 @default.
• W4253240757 creator A5052837648 @default.
• W4253240757 creator A5053557508 @default.
• W4253240757 creator A5055844000 @default.
• W4253240757 creator A5062897812 @default.
• W4253240757 date "2013-03-13" @default.
• W4253240757 modified "2023-10-18" @default.
• W4253240757 title "The antibodies cyclic citrullinated peptides (anti-CCP) positivity could be a promising marker in brucellosis patients presented with peripheric arthritis" @default.
• W4253240757 cites W1964539908 @default.
• W4253240757 cites W1967211753 @default.
• W4253240757 cites W1974512065 @default.
• W4253240757 cites W1992274911 @default.
• W4253240757 cites W2013573826 @default.
• W4253240757 cites W2017236912 @default.
• W4253240757 cites W2025291938 @default.
• W4253240757 cites W2029404678 @default.
• W4253240757 cites W2032221360 @default.
• W4253240757 cites W2051237647 @default.
• W4253240757 cites W2060394452 @default.
• W4253240757 cites W2075477974 @default.
• W4253240757 cites W2108595441 @default.
• W4253240757 cites W2113060075 @default.
• W4253240757 cites W2118920784 @default.
• W4253240757 cites W2152348310 @default.
• W4253240757 cites W2163363403 @default.
• W4253240757 cites W2167539659 @default.
• W4253240757 doi "https://doi.org/10.1007/s10165-013-0857-4" @default.
• W4253240757 hasPublicationYear "2013" @default.
• W4253240757 type Work @default.
• W4253240757 citedByCount "3" @default.
• W4253240757 countsByYear W42532407572014 @default.
• W4253240757 countsByYear W42532407572015 @default.
• W4253240757 crossrefType "journal-article" @default.
• W4253240757 hasAuthorship W4253240757A5014873964 @default.
• W4253240757 hasAuthorship W4253240757A5016930658 @default.
• W4253240757 hasAuthorship W4253240757A5017389872 @default.
• W4253240757 hasAuthorship W4253240757A5031250517 @default.
• W4253240757 hasAuthorship W4253240757A5037729679 @default.
• W4253240757 hasAuthorship W4253240757A5052837648 @default.
• W4253240757 hasAuthorship W4253240757A5053557508 @default.
• W4253240757 hasAuthorship W4253240757A5055844000 @default.
• W4253240757 hasAuthorship W4253240757A5062897812 @default.
• W4253240757 hasConcept C126322002 @default.
• W4253240757 hasConcept C159654299 @default.
• W4253240757 hasConcept C198451711 @default.
• W4253240757 hasConcept C203014093 @default.
• W4253240757 hasConcept C2776232647 @default.
• W4253240757 hasConcept C2777077863 @default.
• W4253240757 hasConcept C2777575956 @default.
• W4253240757 hasConcept C2781429187 @default.
• W4253240757 hasConcept C71924100 @default.
• W4253240757 hasConcept C90924648 @default.
• W4253240757 hasConceptScore W4253240757C126322002 @default.
• W4253240757 hasConceptScore W4253240757C159654299 @default.
• W4253240757 hasConceptScore W4253240757C198451711 @default.
• W4253240757 hasConceptScore W4253240757C203014093 @default.
• W4253240757 hasConceptScore W4253240757C2776232647 @default.
• W4253240757 hasConceptScore W4253240757C2777077863 @default.
• W4253240757 hasConceptScore W4253240757C2777575956 @default.
• W4253240757 hasConceptScore W4253240757C2781429187 @default.
• W4253240757 hasConceptScore W4253240757C71924100 @default.
• W4253240757 hasConceptScore W4253240757C90924648 @default.
• W4253240757 hasLocation W42532407571 @default.
• W4253240757 hasOpenAccess W4253240757 @default.
• W4253240757 hasPrimaryLocation W42532407571 @default.
• W4253240757 hasRelatedWork W1978435955 @default.
• W4253240757 hasRelatedWork W1981471379 @default.
• W4253240757 hasRelatedWork W1999301958 @default.
• W4253240757 hasRelatedWork W2023721760 @default.
• W4253240757 hasRelatedWork W2031170496 @default.
• W4253240757 hasRelatedWork W2155117280 @default.
• W4253240757 hasRelatedWork W2293819614 @default.
• W4253240757 hasRelatedWork W2350091741 @default.
• W4253240757 hasRelatedWork W2412341873 @default.
• W4253240757 hasRelatedWork W2912447547 @default.
• W4253240757 isParatext "false" @default.
• W4253240757 isRetracted "false" @default.
• W4253240757 workType "article" @default.